Entero Healthcare Solutions Ltd
Entero Healthcare Solutions Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
3 of 3 strong
The short version
Entero Healthcare Solutions targets consolidated revenue growth of approximately 23% year-on-year for FY27, excluding any major new acquisitions. Entero Healthcare projects a consolidated revenue growth of approximately 23% year-on-year for FY27, with a 5% EBITDA margin and 50% EBITDA to operating cash flow conversion.
From Entero Healthcare Solutions Ltd's Q1 FY27 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- Entero Healthcare Solutions targets consolidated revenue growth of approximately 23% year-on-year for FY27, excluding any major new acquisitions.
- The company aims to grow at an excess of 20% over the medium term (3 to 4 years), combining both organic and inorganic growth.
- Focus for FY27 is primarily on organic growth by deepening existing relationships and expanding wallet share with current customers.
- MedTech revenue is expected to cross INR 1,000 crores organically in FY27, contributing higher margins and growth.
- Growth outperforming the industry (IPM) is driven by better service levels, wider product range, and stronger collaborations.
2 more points from Entero Healthcare Solutions Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Entero Healthcare Solutions Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No explicit mention of major capex or strategic investments planned for FY27.
- Management indicates there will not be any major acquisitions in FY27 but keeps options open for smaller deals.
- Cash generated (50% of EBITDA converted to operating cash flow after working capital) will be deployed either for acquisitions, debt reduction, or buying out minority interests, whichever best enhances EPS.
- Depreciation levels are expected to remain steady going forward, subject to no major capex.
2 more points from Entero Healthcare Solutions Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Retailing
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Entero Healthcare Solutions Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Entero Healthcare Solutions Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Entero Healthcare Solutions Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.9K Cr, net profit ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Entero Healthcare Solutions Ltd's management said in earlier quarters
Others in Retailing this season
- Trent Ltd (Q1 FY27)
Q1 FY27 revenue from operations: ₹5,666 crore (Standalone), ₹5,755 crore (Consolidated) . Key concall takeaways from Trent Ltd's Q1 FY27 earnings call — and…
- Shiprocket (Q1 FY27)
Core business shipments have grown by 31%, with revenue growing at 22%, indicating healthy volume-driven growth. Key concall takeaways from Shiprocket Ltd's Q1…
- Spencers Retail Ltd (Q1 FY27)
Consolidated revenue grew 13% YoY to Rs. Key concall takeaways from Spencers Retail Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Aditya Birla Fashion & Retail Ltd (Q1 FY27)
10% space addition). Key concall takeaways from Aditya Birla Fashion & Retail's Q1 FY27 earnings call — and how it ranks against sector peers.
Arthneeti Pro · Annual
Entero Healthcare Solutions Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Entero Healthcare Solutions Ltd Q1 FY27 results?
Entero Healthcare Solutions targets consolidated revenue growth of approximately 23% year-on-year for FY27, excluding any major new acquisitions. Entero Healthcare projects a consolidated revenue growth of approximately 23% year-on-year for FY27, with a 5% EBITDA margin and 50% EBITDA to operating cash flow conversion.
What is Entero Healthcare Solutions Ltd share price analysis?
Entero Healthcare Solutions Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 48.0 with a market cap of ₹6,196 Cr. Investors should review the full earnings analysis for detailed insights.
Is Entero Healthcare Solutions Ltd planning capital expenditure?
No explicit mention of major capex or strategic investments planned for FY27.
Keep Entero Healthcare Solutions Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.